Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 224

Results For "CRO"

4413 News Found

Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr
News | August 06, 2023

Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr

The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023


Fortis Healthcare Q1 FY24 consolidated PAT drops at Rs. 111.76 Cr
News | August 06, 2023

Fortis Healthcare Q1 FY24 consolidated PAT drops at Rs. 111.76 Cr

Fortis Healthcare has reported total income of Rs. 1665.55 crores during the period ended June 30, 2023


Indraprastha Medical Corporation Q1 FY24 PAT up at Rs. 30.50 Cr
News | August 06, 2023

Indraprastha Medical Corporation Q1 FY24 PAT up at Rs. 30.50 Cr

The company has reported total income of Rs. 310.07 crores during the period ended June 30, 2023


Yashoda Medicity, Indirapuram and Draeger India join hands to establish modular ICU setup
Healthcare | August 05, 2023

Yashoda Medicity, Indirapuram and Draeger India join hands to establish modular ICU setup

Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes


Zydus Wellness posts Q1 FY24 consolidated PAT at Rs. 110.4 Cr
News | August 04, 2023

Zydus Wellness posts Q1 FY24 consolidated PAT at Rs. 110.4 Cr

The company has reported total income of Rs. 704.5 crores during the period ended June 30, 2023


Dabur India posts Q1 FY24 PAT at Rs. 463.88 Cr
News | August 04, 2023

Dabur India posts Q1 FY24 PAT at Rs. 463.88 Cr

The company has posted net profit of Rs. 463.88 crores for the period ended June 30, 2023


Lupin posts Q1 FY24 consolidated PAT at Rs. 452.26 Cr
News | August 04, 2023

Lupin posts Q1 FY24 consolidated PAT at Rs. 452.26 Cr

The company has reported total income of Rs. 4836.89 crores during the period ended June 30, 2023


Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr
News | August 04, 2023

Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr

The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023


Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr
News | August 03, 2023

Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr

The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023